Published in Acta Virol on May 01, 1977
Dynamics of immunofluorescence and infectivity of parainfluenza 3 virus in susceptible cells. Acta Virol (1967) 0.93
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
Effective inhibition of viral reproduction by hydrophobised antiviral antibodies. Biomed Sci (1990) 0.76
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Characteristics of antiviral immunity in children with the atopic form of bronchial asthma]. Pediatriia (1989) 0.75
[Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis]. Ter Arkh (1983) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[The application of radial hemolysis technique in detection of antibodies to avian influenza virus A (H5N1) and pandemic virus A (H1N1) pdm09]. Klin Lab Diagn (2012) 0.75
[Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children]. Vestn Ross Akad Med Nauk (1996) 0.75
[Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses]. Vopr Virusol (2014) 0.75
[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol (2015) 0.75
Comparative studies on influenza B virus. I. Biological properties and polypeptide composition of strains isolated in different years. Acta Virol (1983) 0.75
Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation. Acta Virol (1988) 0.75
[Class I histocompatibility antigens as markers of human susceptibility to influenza A viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Development of competitive enzyme immunoassay for the detection of influenza A(H5) virus antibodies]. Klin Lab Diagn (2010) 0.75
[Preparation and characteristics of the antigenic properties of tissue influenza diagnostic agents]. Tr Inst Im Pastera (1982) 0.75
[THE COMPARATIVE ANALYSIS OF EFFECTIVENESS OF QUICK TESTS IN DIAGNOSTIC OF INFLUENZA AND RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN]. Klin Lab Diagn (2015) 0.75
[siRNA-mediated inhibition of respiratory syncytial virus replication]. Vopr Virusol (2007) 0.75
[Use of the method of quantitative calculation of fluorescing cells in the study of the periods of absorption and permeability to para-influenza type 2 virus in sensitive cells]. Vopr Virusol (1969) 0.75
[Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980]. Vopr Virusol (1982) 0.75
[Population heterogeneity of modern influenza B virus strains]. Mikrobiol Zh (1980) 0.75
[Isolation and characteristics of anti-adenovirus monoclonal antibodies in immunoenzyme and immunofluorescent reactions]. Vopr Virusol (2001) 0.75
[Ultrastructural changes in the cells of human embryo lung fibroblasts in the reproduction of the coronavirus HCoV/SPb/01/03]. Vopr Virusol (2006) 0.75
[Determination of the diagnostic parameters of domestic immunoenzyme test systems versus foreign analogues in the detection of serum rubella virus antibodies]. Klin Lab Diagn (2010) 0.75
[New monoclonal kits for the diagnosis of the adenoviral infection]. Vopr Virusol (2014) 0.75
[Characterization of biological properties and glycopeptide composition of influenza virus type A grown in different cell systems]. Virologie (1979) 0.75
[Development of influenza surveillance in Russia in the system of the WHO national influenza center]. Vopr Virusol (2013) 0.75
[Influenza A virus antigens in children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Rapid preparation of inhibitor-resistant clones of the influenza A viruses for diagnostic purposes]. Tr Inst Im Pastera (1982) 0.75
[The age-related specificity of site-oriented immunity in respiratory-syncytial virus infection]. Vopr Virusol (2004) 0.75
[Study of the harmlessness, antigenicity and immunogenic activity of live antiparainfluenza vaccine]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek (2006) 0.75
[Characteristics of monoclonal antibodies to RS virus in immunoenzyme and immunofluorescence techniques]. Vestn Ross Akad Med Nauk (1995) 0.75
[Humoral antiviral immunity in children with hematologic neoplasms]. Vopr Virusol (1995) 0.75
Comparative studies on influenza B virus. II. The effect of host cells on biological properties and polypeptide composition. Acta Virol (1983) 0.75
[Use of droplet microreaction of complement fixation for the diagnosis of viral respiratory infections]. Lab Delo (1973) 0.75
Improved methods of influenza virus propagation. II. Characteristics of cell culture and allantoic virus preparations. Acta Virol (1977) 0.75
[Influenza vaccine stimulation of antibodies to different variants of influenza A virus]. Vopr Virusol (1985) 0.75
[Genetic predisposition to latent influenza A virus in children with blood type B(III) as a possible cause of new epidemiologic strains in the countries of South-Eastern Asia]. Vestn Ross Akad Med Nauk (1994) 0.75
[Structure and antiviral activity of adamantane-containing polymer preparation]. Vopr Virusol (2003) 0.75
[The use of the radial hemolysis reaction for demonstrating antibodies to the surface antigens of the influenza virus in assessing postvaccinal immunity]. Mikrobiol Zh (1990) 0.75
[Production of monoclonal antibodies to the human respiratory syncytial virus]. Vestn Ross Akad Med Nauk (1994) 0.75
[Analysis of etiology of influenza-like morbidity and monitoring influenza epidemic of 1998-1999 by laboratory diagnosis methods]. Vestn Ross Akad Med Nauk (2001) 0.75
[Development of immunoenzyme assay for subtype-specific detection of antibodies to influenza viruses A (H1N1) and A (H3N2)]. Vopr Virusol (2002) 0.75
[The phenotypic characteristics of healthy carriers of the antigenic structures of the influenza A virus]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75
[Development of new approaches to standartization of enzyme immunoassay test systems for detection of antibodies to respiratory syncytial virus using electron microscopy and monoclonal antibodies]. Vopr Virusol (2000) 0.75